학술논문
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (Review of NICE technology appraisals 162 and 175): A systematic review and economic evaluation
Document Type
Article
Author
Source
In: Health Technology Assessment . (Health Technology Assessment, 2015, 19(47):1-8)
Subject
Language
English
ISSN
20464924
13665278
13665278